Aralez Bio

Aralez Bio has developed a proprietary enzymatic platform that enables the sustainable and scalable production of thousands of noncanonical amino acids (ncAAs), which are used as advanced building blocks in peptide medicinal chemistry. Their technology—originating from Nobel Prize-winning research—allows rapid synthesis with high yield and purity at commercial scale. The company supplies these ncAAs to pharmaceutical companies and collaborates on next-generation therapeutic development by unlocking new chemical space inaccessible with standard amino acids. They have established revenue-generating partnerships with top global pharma companies.